Published:
Improvements proposed to level playing field for dietary supplements exporters
New Zealand proposes to modernise dietary-supplement rules to cut red tape, remove double compliance with importing-country rules, and allow certain exemptions (with products exempted from NZ rules not sold domestically).
New Zealand is proposing changes to modernise the rules governing dietary supplements, with the stated goal of cutting red tape for exporters while maintaining consumer safety. Food Safety Minister Andrew Hoggard said the reforms would stop many exporters being required to comply with both New Zealand’s labelling/composition requirements and those of the importing country, which the Government characterises as unnecessary duplication.
Under the proposals, exporters would need to meet only the requirements of the importing country for labelling and composition. The Government also proposes that exporters could make therapeutic claims in line with importing-country requirements, and that certain products could be exempted from New Zealand compositional requirements for food additives and from maximum daily dose limits for vitamins and minerals. Importantly, products granted an exemption under the new rules would not be allowed to be sold in New Zealand and should be sold only in the market where they meet that jurisdiction’s requirements.
The Government links this to earlier steps, including food-exporter exemptions announced last year, and notes targeted consultation in November 2025 with an industry body representing 80% of the sector, which it says supported updating regulations to enable trade. Updated regulations are being drafted and are intended to go back to Cabinet for approval.
For FX traders, the key thing to watch next is how quickly Cabinet approves the changes and whether they translate into improved export competitiveness and volumes for New Zealand’s supplement sector, which would feed into expectations for New Zealand’s trade outlook and NZD.
Why this matters for FX
The proposed regulatory changes aim to reduce compliance costs and barriers for New Zealand dietary supplements exporters by avoiding “double-up” with importing-country labelling and composition requirements, and by aligning therapeutic-claim rules to the destination market. While this is not a monetary-policy or inflation driver, it can affect New Zealand’s trade performance and external demand marginally by improving export competitiveness and possibly volumes. That matters most for NZD via the trade balance/channel—especially if it supports a growing export niche over time—though the immediate FX impact is likely limited.